Skip to main content
Diasorin logo

Diasorin — Investor Relations & Filings

Ticker · DIA ISIN · IT0003492391 LEI · 8156002878BDF0EE4348 XMIL Manufacturing
Open in API
Filings indexed 809 across all filing types
Latest filing 2025-12-22 Report Publication Anno…
Country IT Italy
Listing XMIL DIA

About Diasorin

https://diasoringroup.com/en

Diasorin is a global leader in the In Vitro Diagnostic (IVD) field, developing, producing, and marketing reagent kits for laboratory diagnostics. The company specializes in immunodiagnostics and molecular diagnostics. Its immunodiagnostics technology is based on detecting antibodies and antigens in fluid samples to identify diseases or measure physiological markers. The molecular diagnostics division provides flexible tools using targeted and multiplex technologies to detect pathogens in biological specimens. Since 2021, Diasorin has also been active in the Life Science business, offering platforms for biomedical research, clinical diagnostics, and drug discovery. Through its product lines, such as the LIAISON® family of analyzers and assays, the company aims to empower healthcare providers with actionable information to improve patient care, enable faster triage, and reduce unnecessary antibiotic use.

Recent filings

Filing Released Lang Actions
Diasorin S.p.A. - Calendario Annuale Eventi Societari 2026
Report Publication Announcement Classification · 95% confidence The document is a 'Calendario Annuale Eventi Societari' (Annual Corporate Events Calendar) for 2026, which lists the dates for board meetings to approve financial results and the shareholder meeting. This type of document is a standard regulatory announcement informing the market of the company's reporting schedule. It does not contain the actual financial reports, but rather the schedule for their release. Therefore, it falls under the category of a Report Publication Announcement (RPA).
2025-12-22 Italian
Publication of documents for the Shareholders’ Meeting to be held on January 27, 2026
Report Publication Announcement Classification · 100% confidence The document is a short announcement (2479 characters) titled 'Publication of documents for the Shareholders' Meeting'. It explicitly states that the company has made explanatory reports and proxy forms available on its website and storage mechanism. Following the 'Menu vs Meal' rule, this is an announcement regarding the publication of documents rather than the documents themselves, making it a Report Publication Announcement (RPA).
2025-12-22 English
Pubblicazione della documentazione per l'Assemblea del 27 gennaio 2026
AGM Information Classification · 95% confidence The document is a very short notification (211 characters) announcing the publication of documentation for an upcoming shareholder meeting (Assemblea) on January 27, 2026. It explicitly states 'Vedasi in allegato' (See attachment), which fits the 'Menu vs Meal' rule for a Report Publication Announcement (RPA).
2025-12-22 Italian
Shareholders' Meeting January 27, 2026 – Designated Representative proxy form (art. 135-novies TUF)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Form' used by shareholders to grant voting authority to a designated representative for an upcoming General Meeting. This type of document is specifically designed to solicit and facilitate shareholder participation and voting, which falls under the category of Proxy Solicitation & Information Statement.
2025-12-22 English
Assemblea degli Azionisti del 27 gennaio 2026 – Modulo delega Rappresentante Designato (art. 135-novies TUF)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a proxy voting form ('Modulo di conferimento della delega') for shareholders of DiaSorin S.p.A. to appoint a designated representative to vote on their behalf at an upcoming General Meeting. This type of document is a standard proxy solicitation material used to facilitate shareholder participation in corporate governance meetings.
2025-12-22 Italian
Shareholders' Meeting January 27, 2026 – Designated Representative proxy form (art. 135-undecies TUF)
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Proxy Form' for a shareholders' meeting, specifically designed for shareholders to appoint a designated representative to vote on their behalf pursuant to Italian Legislative Decree 58/1998. This type of document is a standard component of proxy solicitation materials provided to shareholders to facilitate voting at an upcoming general meeting. According to the provided definitions, 'Proxy Solicitation & Information Statement' (PSI) is the correct category for materials sent to shareholders to request votes for meetings.
2025-12-22 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.